They found that increased Ki67 staining in immune-enriched tumor locations (2-fold increase in responders; p ≤ 0.001) and HER2 staining in tumor predominant locations (3.5-fold increase in responders; p ≤ 0.001) were associated with NAC response. This evidence concerns the gene ERBB2 and neoplasm.